Northwest Biotherapeutics (NWBO) Return on Sales Growth (1y) (2011 - 2026)
Northwest Biotherapeutics (NWBO) Return on Sales Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.84 Bn | 467.05 Bn | 1.35 Bn | 0.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 0.00 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 0.00 |
| 10 | Northwest Biotherapeutics | 277.35 Mn | 275.56 Mn | - | 24.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.00 |
| Dec 31, 2025 | 90.00 |
| Sep 30, 2025 | -37.00 |
| Jun 30, 2025 | -151.00 |
| Mar 31, 2025 | 10.00 |
| Dec 31, 2024 | -87.00 |
| Sep 30, 2024 | -9.00 |
| Jun 30, 2024 | 36.00 |
| Mar 31, 2024 | -45.00 |
| Dec 31, 2023 | 6.00 |
| Sep 30, 2023 | 594.00 |
| Jun 30, 2023 | -27.00 |
| Mar 31, 2023 | 19.00 |
| Dec 31, 2022 | 25.00 |
| Sep 30, 2022 | -599.00 |
| Jun 30, 2022 | -15.00 |
| Mar 31, 2022 | 53.00 |
| Dec 31, 2021 | -17.00 |
| Sep 30, 2021 | 214.00 |
| Jun 30, 2021 | 4,286.00 |